Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04664192 · ClinicalTrials.gov registry record

Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research

A clinical trial of Respiratory Failure and Interstitial Lung Disease, sponsored by Baylor Research Institute.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT04664192 is a study of Respiratory Failure and Interstitial Lung Disease that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 100 participants, below the 4,521-participant average among 40 other Respiratory Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04664192, a study of Respiratory Failure and Interstitial Lung Disease, is actively recruiting participants, sponsored by Baylor Research Institute.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

A major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effects of viral and other infectious exposures to outcomes in our lung transplant and ALD patient populations.

Interventions

  • OTHER Patient Biospecimen Registry (observational and blood sampling)

Study Locations (1)

Texas

  • Baylor Scott & White Research Institute - Dallas

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2021-06-04
Est. Completion 2026-12-01

Sponsor

Baylor Research Institute

180 total trials

What the Registry Record Tells You About NCT04664192

The ClinicalTrials.gov registry entry for NCT04664192 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,521-participant average among 40 other Respiratory Failure trials with a reported enrollment target (98% lower). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Respiratory Failure appearing as the primary indexed condition, and to 1 intervention - of which Patient Biospecimen Registry (observational and blood sampling) is the first listed.

NCT04664192 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04664192 about?

NCT04664192 is a clinical study titled "Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research". A major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effects of viral and other infectious exposures to outcomes in our lung transplant and ALD patient populations.

What is the current status of trial NCT04664192?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-06-04. Estimated completion is 2026-12-01.

What conditions does trial NCT04664192 study?

This clinical trial studies the following conditions: Respiratory Failure, Interstitial Lung Disease, Lung Diseases.

What interventions are being tested in trial NCT04664192?

The interventions under investigation include: Patient Biospecimen Registry (observational and blood sampling) (OTHER).

Who is sponsoring clinical trial NCT04664192?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04664192 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.